Cargando…

Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells

Yersinia are Gram-negative zoonotic bacteria that use a type III secretion system (T3SS) to inject Yersinia outer proteins into the host cytosol to subvert essential components of innate immune signaling. However, Yersinia virulence activities can elicit activation of inflammasomes, which lead to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jenna, Brodsky, Igor E., Shin, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653943/
https://www.ncbi.nlm.nih.gov/pubmed/37615436
http://dx.doi.org/10.1128/mbio.01310-23
_version_ 1785136523499274240
author Zhang, Jenna
Brodsky, Igor E.
Shin, Sunny
author_facet Zhang, Jenna
Brodsky, Igor E.
Shin, Sunny
author_sort Zhang, Jenna
collection PubMed
description Yersinia are Gram-negative zoonotic bacteria that use a type III secretion system (T3SS) to inject Yersinia outer proteins into the host cytosol to subvert essential components of innate immune signaling. However, Yersinia virulence activities can elicit activation of inflammasomes, which lead to inflammatory cell death and cytokine release to contain infection. Yersinia activation and evasion of inflammasomes have been characterized in murine macrophages but remain poorly defined in human cells, particularly intestinal epithelial cells (IECs), a primary site of intestinal Yersinia infection. In contrast to murine macrophages, we find that in both human IECs and macrophages, Yersinia pseudotuberculosis T3SS effectors promote evasion of the caspase-4 inflammasome, which senses cytosolic lipopolysaccharide. The anti-phagocytic YopE and YopH, as well as the translocation regulator YopK, were collectively responsible for evading inflammasome activation, in part by inhibiting Yersinia internalization mediated by YadA and β1-integrin signaling. These data provide insight into the mechanisms of Yersinia-mediated inflammasome activation and evasion in human cells and reveal species-specific differences underlying the regulation of inflammasome responses to Yersinia. IMPORTANCE: Yersinia are responsible for significant disease burden in humans, ranging from recurrent disease outbreaks (yersiniosis) to pandemics (Yersinia pestis plague). Together with rising antibiotic resistance rates, there is a critical need to better understand Yersinia pathogenesis and host immune mechanisms, as this information will aid in developing improved immunomodulatory therapeutics. Inflammasome responses in human cells are less studied relative to murine models of infection, though recent studies have uncovered key differences in inflammasome responses between mice and humans. Here, we dissect human intestinal epithelial cell and macrophage inflammasome responses to Yersinia pseudotuberculosis. Our findings provide insight into species- and cell type-specific differences in inflammasome responses to Yersinia.
format Online
Article
Text
id pubmed-10653943
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-106539432023-08-24 Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells Zhang, Jenna Brodsky, Igor E. Shin, Sunny mBio Research Article Yersinia are Gram-negative zoonotic bacteria that use a type III secretion system (T3SS) to inject Yersinia outer proteins into the host cytosol to subvert essential components of innate immune signaling. However, Yersinia virulence activities can elicit activation of inflammasomes, which lead to inflammatory cell death and cytokine release to contain infection. Yersinia activation and evasion of inflammasomes have been characterized in murine macrophages but remain poorly defined in human cells, particularly intestinal epithelial cells (IECs), a primary site of intestinal Yersinia infection. In contrast to murine macrophages, we find that in both human IECs and macrophages, Yersinia pseudotuberculosis T3SS effectors promote evasion of the caspase-4 inflammasome, which senses cytosolic lipopolysaccharide. The anti-phagocytic YopE and YopH, as well as the translocation regulator YopK, were collectively responsible for evading inflammasome activation, in part by inhibiting Yersinia internalization mediated by YadA and β1-integrin signaling. These data provide insight into the mechanisms of Yersinia-mediated inflammasome activation and evasion in human cells and reveal species-specific differences underlying the regulation of inflammasome responses to Yersinia. IMPORTANCE: Yersinia are responsible for significant disease burden in humans, ranging from recurrent disease outbreaks (yersiniosis) to pandemics (Yersinia pestis plague). Together with rising antibiotic resistance rates, there is a critical need to better understand Yersinia pathogenesis and host immune mechanisms, as this information will aid in developing improved immunomodulatory therapeutics. Inflammasome responses in human cells are less studied relative to murine models of infection, though recent studies have uncovered key differences in inflammasome responses between mice and humans. Here, we dissect human intestinal epithelial cell and macrophage inflammasome responses to Yersinia pseudotuberculosis. Our findings provide insight into species- and cell type-specific differences in inflammasome responses to Yersinia. American Society for Microbiology 2023-08-24 /pmc/articles/PMC10653943/ /pubmed/37615436 http://dx.doi.org/10.1128/mbio.01310-23 Text en Copyright © 2023 Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Zhang, Jenna
Brodsky, Igor E.
Shin, Sunny
Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title_full Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title_fullStr Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title_full_unstemmed Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title_short Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells
title_sort yersinia deploys type iii-secreted effectors to evade caspase-4 inflammasome activation in human cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653943/
https://www.ncbi.nlm.nih.gov/pubmed/37615436
http://dx.doi.org/10.1128/mbio.01310-23
work_keys_str_mv AT zhangjenna yersiniadeploystypeiiisecretedeffectorstoevadecaspase4inflammasomeactivationinhumancells
AT brodskyigore yersiniadeploystypeiiisecretedeffectorstoevadecaspase4inflammasomeactivationinhumancells
AT shinsunny yersiniadeploystypeiiisecretedeffectorstoevadecaspase4inflammasomeactivationinhumancells